LYNPARZA
LYNPARZA
Approved
DIN Number
02475219
Drug Class
Human
Market Date
May 23, 2018
Company
HC
astrazeneca canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02475219
AIG Number0158110003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01XK01 OLAPARIB
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
OLAPARIBActive
Strength: 150 MG
Monograph: OLAPARIB